Back to Results
First PageMeta Content
Chemistry / Health / Medicine / Influenza / Summary of Product Characteristics / Yellow Card Scheme / Neuraminidase inhibitors / Acetamides / Oseltamivir


August[removed]Direct Healthcare Professional Communication on new concentration and dosing instructions of TAMIFLU® oral suspension (oseltamivir phosphate) Dear Healthcare Professional, Roche Products Limited would like
Add to Reading List

Document Date: 2012-08-31 10:14:20

Open Document

File Size: 314,71 KB

Share Result on Facebook

City

Movianto Northern / /

Company

Roche Products Limited / Alliance Healthcare Ltd / AAH Pharmaceuticals Ltd / Michelle Rashford Medical Director Roche Products Limited / Special Roche Products Limited / /

Country

United Kingdom / /

/

/

IndustryTerm

Healthcare professionals / /

MedicalCondition

pandemic influenza / clinically diagnosed influenza / influenza virus / influenza / /

Organization

EMA / European Union / Medicines and Healthcare products Regulatory Agency / Commission on Human Medicines / /

/

Position

Governor / /

Product

TAMIFLU / Oral Suspension / /

Region

Northern Ireland / /

Technology

http / /

URL

http /

SocialTag